Nashville, TN – According to filings with the U.S. Securities and Exchange Commission, VenoStent is raising $3,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Timothy Boire played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About VenoStent

Developing bioengineered smart polymers to transform vascular surgery. VenoStent strives to address dialysis issues with its development of SelfWrap – a perivascular wrap designed to reduce failures at the vein-artery or vein-graft junction of dialysis patients. SelfWrap aims to reduce collapse of the vein at this critical interface by promoting outward vein growth and providing durable, flexible, custom-fit mechanical support.

To learn more about VenoStent, visit http://www.venostent.com/

Contact:
Timothy Boire, President and Chief Executive Officer
603-930-9407
https://www.linkedin.com/in/timothy-boire-283bab10/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved